24.7.2023 11:17:03 CEST | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state
Reference is made to the announcement by Aqua Bio Technology ASA on 23 July 2023 concerning, among other things, a private placement with total gross proceeds of NOK 76 million and a contemplated subsequent offering (the “Subsequent Offering”).
Date on which the terms of the Subsequent Offering was announced:
23 July 2023
Last day including right:
23 July 2023
First day excluding right:
24 July 2023
Record date:
25 July 2023
EGM date:
On or around 31 August 2023
Maximum number of new shares:
[Will be announced later]
Subscription price:
NOK 3
Shall the rights be listed
No
The formal resolution (including final number of shares to be offered) related to the Subsequent Offering will be made by the board of directors at a later time, and further information will be given in due course.
This information is published in accordance with the requirements of the Continuing Obligations.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
Håvard Lindstrøm, 004794132288, hl@aquabiotech.no
About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainablebiotechnology for use in skin care products. ABT’s cosmetics ingredients arehighly effective and they provide the cosmetics industry with naturalalternatives to traditional ingredients. ABT is also marketing and distributingnatural skin care products developed by partners towards consumers andprofessional users. Aqua Bio Technology is listed on Euronext Expand.
Attachments
Download announcement as PDF.pdf
